Skip to main content

Table 4 Correlation of sera autoantibodies to MUC1 glycopeptide combinational subset with clinical variables

From: Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

   Autoantibody positive   Strong autoantibody positiveA
  NB % positive NA,B % positive
Age at diagnosis   P = 0.001 C   P < 0.001
<50 63 5 61 2
50 to 59 132 14 125 9
60 to 69 136 27 129 23
70+ 64 27 57 18
Stage   P = 0.215   P = 0.104
Node negative 200 22 189 17
Node positive 193 17 181 11
Positive nodes   P = 0.195   P = 0.219
0 200 22 189 17
1 to 3 124 19 114 12
4+ 69 12 67 9
Clin tumour size   P = 0.483   P = 0.306
0 to 2 cm 133 19 129 16
2.1 to 4 cm 176 20 162 13
>4 cm 74 14 70 9
Tumour grade/type   P = 0.165   P = 0.016
ID Grade I 37 30 35 26
ID Grade II + I Lob 195 19 187 15
ID Grade III 120 16 109 7
ER Status   P = 0.883   P = 0.183
ER negative 131 18 120 11
ER positive 211 19 204 16
Parity   P = 0.730   P = 0.436
0 children 87 23 82 18
1 to 2 children 171 19 164 16
3+ children 96 19 88 11
Metastases to 15 yrs   P = 0.058   P = 0.028
No 238 22 237 17
Yes 155 14 133 9
  1. A Weak positives excluded
  2. B Total number in that group for the variable.
  3. C Using Chi-squared test for equality of distributionsBold text indicates a significant correlation.